Validic

Remote patient monitoring technology, which delivers patient-generated health data, can help improve the quality of care, particularly in the case of reducing readmissions.

Digital health technologies are providing pharma companies with actionable insights into the medication-taking behaviors of trial participants.

Connected health - technology-enabled care solutions that facilitate communication between patients, providers and caregivers - is becoming more prevalent in the United States and spreading across the globe.

Engaging with patients through mobile or other means for preventive care measures helps healthcare providers improve clinical outcomes and control costs at a time of expanding physician shortage.

As part two of a four-part article series, CEO Ryan Beckland will detail the current trends in the healthcare industry, key drivers of those trends and how technology will be powering new models of care.

Patient-generated health data is proving to be critical in the shift to value-based care.

By Marc Sebes, VP of Product Management In-home clinical devices are among a number of digital health technologies that are being used to streamline clinical trial processes and enable pharmaceutical companies and contract research organizations (CROs) to monitor participants remotely.

(SPONSORED) There is an unprecedented convergence occurring between healthcare and technology – and telemedicine is an increasingly important initiative in the connected health market.

(SPONSORED) The year ahead offers some promising trends—and optimizing the full potential of digital health will be the key to real progress.

(SPONSORED) As the second installment of the two-part series on digital health's impact on pharma, CEO Ryan Beckland addresses remote patient monitoring and patient-generated health data.